Testing a faster way to diagnose and treat hepatitis C

This trial is testing whether a faster way to diagnose and start hepatitis C treatment works well for people who inject drugs. Researchers are comparing two approaches: one that follows the standard step-by-step process, and one that lets people start sofosbuvir and velpatasvir (a two-drug combination) on the same day as their initial test. The goal is to see if skipping one confirmation step still leads to successful treatment while making care simpler and less expensive.

People who inject drugs often face barriers to hepatitis C care, including multiple appointments and delays before treatment starts. This trial exists to see whether this treatment can be offered faster and more simply without sacrificing safety or cure rates, especially in countries with fewer healthcare resources.